Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.60 |
| ▸ | BAD | Q92934 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | RXRA | P19793 | 3/20 | 0.54 |
| ▸ | RXRB | P28702 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14140355 | 1.00 | BCL2L1 (0.60) | BCL2L1BADTP53TSHRHAO1 | |
| SCHEMBL71380 | 0.92 | TSHR (0.71) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL6547995 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| Hydrochloric Acid SCHEMBL532752 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL9317004 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL8767088 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL8487555 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL9318309 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL10604961 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA | |
| SCHEMBL10614159 | 0.90 | TSHR (0.67) | TP53TSHRCES2CES1RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708370-A | ASNF-M/SiO2@CPs hybrid copolymer gel and preparation method thereof | 盐城市友普环保科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| US-20180282257-A1 | Aromatic Monoester Compositions and Processes for Preparing Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-10-04 | — | — | US | claimed |
| EP-1534689-A1 | NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-06-01 | — | — | EP | claimed |
| US-20040242572-A1 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-02 | — | — | US | claimed |
| WO-2004024702-A1 | NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-03-25 | — | — | WO | claimed |
| JP-57108056-A | — | — | None | — | — | JP | disclosed |
| JP-54048740-A | — | — | None | — | — | JP | disclosed |
| US-12480049-B2 | Compound and liquid crystal composition | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-11-25 | — | — | US | disclosed |
| CN-119708370-A | ASNF-M/SiO2@CPs hybrid copolymer gel and preparation method thereof | 盐城市友普环保科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-4368614-A1 | SYNTHESIS AND APPLICATION OF PHOSPHATASE DEGRADER | Hinova Pharmaceuticals Inc. (CN) | 2024-05-15 | — | — | EP | disclosed |
| EP-3269789-B1 | LIGHT EMITTING MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-20230250338-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-08-10 | — | — | US | disclosed |
| US-5922763-A | ANTICOAGULANT; CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1999-07-13 | — | — | US | disclosed |
| US-5736559-A | CARDIOVASCULAR DISORDERS; RESPIRATORY SYSTEM DISORDERS | KARL THOMAE GMBH (DE) | 1998-04-07 | — | — | US | disclosed |
| US-5597825-A | AGGREGATION INHIBITORS | DR. KARL THOMAE GMBH (DE) | 1997-01-28 | — | — | US | disclosed |
| US-5580741-A | INCUBATING SAMPLE SOLUTION IN CONTAINER PRECOATED WITH ANTIBODY AND PROTEIN CONJUGATE YIELDS COMPLEXES, THEN REMOVAL AND REACTION WITH CHEMILUMINESCENT REAGENTS FOR MEASUREMENT OF LIGHT INTENSITY, FOR CHLORINATED BIPHENYLS | GENERAL ELECTRIC COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0425930-B1 | Process for the preparation of symmetrical diarylacetylenes | BAYER AG (DE) | 1994-09-28 | — | — | EP | disclosed |
| US-5185454-A | Reacting aryl bromide with acetylene in presence of palladium catalyst and nitrogen-containing heterocyclic base | BAYER AKTIENGESELLSCHAFT (DE) | 1993-02-09 | — | — | US | disclosed |
| JP-S57108056-A | 4'-(ALKYLOXYMETHYL)-4-CYANOBIPHENYL | CHISSO CORP | 1982-07-05 | — | — | JP | disclosed |
| JP-S5448740-A | BIPHENYL ESTERS | SEIKO EPSON CORP | 1979-04-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242572-A1 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | MCHR2, MCHR1, NPY1R | BCL2L1 3731/4885BAD 2116/4885TP53 4875/4885 |
| US-20180282257-A1 | Aromatic Monoester Compositions and Processes for Preparing Same | ADH1A, ADH1C, GK | BCL2L1 3249/4885BAD 3277/4885TP53 1710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.